-
1
-
-
0027925168
-
New concepts about the mast cell
-
GALLI SJ: New concepts about the mast cell. N. Engl. J. Med. (1993) 328(4):257-265.
-
(1993)
N. Engl. J. Med.
, vol.328
, Issue.4
, pp. 257-265
-
-
Galli, S.J.1
-
2
-
-
0032970154
-
The high-affinity IgE receptor (Fc_RI) from physiology to pathology
-
KINET JP: The high-affinity IgE receptor (Fc_RI) from physiology to pathology. Ann. Rev. Immunol. (1999) 17 931-972.
-
(1999)
Ann. Rev. Immunol.
, vol.17
, pp. 931-972
-
-
Kinet, J.P.1
-
3
-
-
0036883552
-
Molecular aspects of allergy
-
MIESCHER SM, VOGEL M: Molecular aspects of allergy. Mol. Aspects Med. (2002) 236(6):413-462.
-
(2002)
Mol. Aspects Med.
, vol.236
, Issue.6
, pp. 413-462
-
-
Miescher, S.M.1
Vogel, M.2
-
4
-
-
0037365426
-
The central role of FcERI in allergy
-
VON BUBNOFF D, NOVAK N, KRAFT S, BIEBER T. The central role of FcERI in allergy. Clin. Exp. Dermatol. (2003) 28 2):184-187.
-
(2003)
Clin. Exp. Dermatol.
, vol.28
, Issue.2
, pp. 184-187
-
-
Von Bubnoff, D.1
Novak, N.2
Kraft, S.3
Bieber, T.4
-
5
-
-
0035546053
-
Effector lymphocytes in autoimmunity
-
SANTAMARIA P: Effector lymphocytes in autoimmunity. Curr. Opin. Immunol. (2001) 13(6):663-669.
-
(2001)
Curr. Opin. Immunol.
, vol.13
, Issue.6
, pp. 663-669
-
-
Santamaria, P.1
-
7
-
-
0034046181
-
Regulation of antibody responses via antibodies, complement, and Fc receptors
-
HEYMAN B: Regulation of antibody responses via antibodies, complement, and Fc receptors. Ann. Rev. Immunol. (2000) 18 709-737.
-
(2000)
Ann. Rev. Immunol.
, vol.18
, pp. 709-737
-
-
Heyman, B.1
-
9
-
-
0036676975
-
Roles of Fc receptors in autoimmunity
-
TAKAI T: Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. (2002) 2(8):580-592.
-
(2002)
Nat. Rev. Immunol.
, vol.2
, Issue.8
, pp. 580-592
-
-
Takai, T.1
-
10
-
-
0036888558
-
Fc receptors are major mediators of antibody based inflammation in autoimmunity
-
HOGARTH PM: Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol. (2002) 14(6):798-802.
-
(2002)
Curr. Opin. Immunol.
, vol.14
, Issue.6
, pp. 798-802
-
-
Hogarth, P.M.1
-
11
-
-
5944247564
-
Fc α/μ receptor mediates endocytosis of IgM-coated microbes
-
SHIBUYA A, SAKAMOTA N, SHIMIZU Y et al.: Fc α/μ receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. (2000) 1(5):441-446.
-
(2000)
Nat. Immunol.
, vol.1
, Issue.5
, pp. 441-446
-
-
Shibuya, A.1
Sakamota, N.2
Shimizu, Y.3
-
12
-
-
2342524131
-
The MHC Class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs
-
ROOPENIAN DC, CHRISTIANSON GJ, SPROULE TJ et al.: The MHC Class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J. Clin. Invest. (2004) 113(9):1328-1333.
-
(2004)
J. Clin. Invest.
, vol.113
, Issue.9
, pp. 1328-1333
-
-
Roopenian, D.C.1
Christianson, G.J.2
Sproule, T.J.3
-
13
-
-
0038414792
-
Role of Fcγ receptors IIA, IIIA, and IIIB in susceptibility to rheumatoid arthritis
-
RADSTAKE TR, PETIT E, PIERLOT C, VAN DE PUTTE LB, CORMELIS F, BARRERA P: Role of Fcγ receptors IIA, IIIA, and IIIB in susceptibility to rheumatoid arthritis. J. Rheumatol. (2003) 30(5):926-933.
-
(2003)
J. Rheumatol.
, vol.30
, Issue.5
, pp. 926-933
-
-
Radstake, T.R.1
Petit, E.2
Pierlot, C.3
Van De Putte, L.B.4
Cormelis, F.5
Barrera, P.6
-
14
-
-
0037994582
-
Studies on the association of Fcγ receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: Evidence for a genetic interaction between HLA-DRB1 and FCGR3A
-
KYOGOKU C, T SUCHIYA N, MATSUTA K, TOKUNAGA K: Studies on the association of Fcγ receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: evidence for a genetic interaction between HLA-DRB1 and FCGR3A. Genes. Immun. (2002) 3 8):488-493.
-
(2002)
Genes Immun.
, vol.3
, Issue.8
, pp. 488-493
-
-
Kyogoku, C.1
Suchiya, N.2
Matsuta, K.3
Tokunaga, K.4
-
15
-
-
0036945842
-
Variations in immune response genes and their associations with multifactorial immune disorders
-
TSUCHIYA N, OHASHI J, TOKUNAGA K: Variations in immune response genes and their associations with multifactorial immune disorders. Immunol. Rev. (2002) 190:169-181.
-
(2002)
Immunol. Rev.
, vol.190
, pp. 169-181
-
-
Tsuchiya, N.1
Ohashi, J.2
Tokunaga, K.3
-
16
-
-
0035983749
-
FcγRIIA-SLE Meta-Analysis Investigators: Role of the Fcγ receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: A meta-analysis
-
KARASSA FB, TRIKALINOS TA, IOANNIDIS JP: FcγRIIA-SLE Meta-Analysis Investigators: role of the Fcγ receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis. Rheum. (2002) 46(6):1563-1571.
-
(2002)
Arthritis Rheum.
, vol.46
, Issue.6
, pp. 1563-1571
-
-
Karassa, F.B.1
Trikalinos, T.A.2
Ioannidis, J.P.3
-
17
-
-
0031283050
-
Analysis of FcγRII gene polymorphisms in Wegener's granulomatosis
-
EDBERG JC, WAINSTEIN E, WU J et al.: Analysis of FcγRII gene polymorphisms in Wegener's granulomatosis. Exp. Clin. Immunogenet. (1997) 14(3):183-195.
-
(1997)
Exp. Clin. Immunogenet.
, vol.14
, Issue.3
, pp. 183-195
-
-
Edberg, J.C.1
Wainstein, E.2
Wu, J.3
-
18
-
-
0033624966
-
Involvement of Fcγ receptor IIIA genotypes in susceptibility to rheumatoid arthritis
-
NIETO A, CALIZ R, PASCUAL M, MATARAN L, GARCIA S, MARTIN J: Involvement of Fcγ receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum. (2000) 43(4):735-739.
-
(2000)
Arthritis Rheum.
, vol.43
, Issue.4
, pp. 735-739
-
-
Nieto, A.1
Caliz, R.2
Pascual, M.3
Mataran, L.4
Garcia, S.5
Martin, J.6
-
19
-
-
0037384322
-
FcγRIIIA-158V and rheumatoid arthritis: A confirmation study
-
MORGAN AW, KEYTE VH, BABBAGE SJ et al.: FcγRIIIA-158V and rheumatoid arthritis: a confirmation study. Rheumatology (2003) 42(4):528-533.
-
(2003)
Rheumatology
, vol.42
, Issue.4
, pp. 528-533
-
-
Morgan, A.W.1
Keyte, V.H.2
Babbage, S.J.3
-
20
-
-
0033188304
-
Association of Fcγ receptor IIIB, but not of Fcγ receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese
-
HATTA Y, TSUCHIYA N, OHASHI J et al.: Association of Fcγ receptor IIIB, but not of Fcγ receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun. (1999) 1(1):53-60.
-
(1999)
Genes Immun.
, vol.1
, Issue.1
, pp. 53-60
-
-
Hatta, Y.1
Tsuchiya, N.2
Ohashi, J.3
-
21
-
-
0034691322
-
The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex
-
SONDERMANN P, HUBER R, OOSTUIZEN V, JACOB U: The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature (2000) 406(6793):267-273.
-
(2000)
Nature
, vol.406
, Issue.6793
, pp. 267-273
-
-
Sondermann, P.1
Huber, R.2
Oostuizen, V.3
Jacob, U.4
-
22
-
-
0034691520
-
Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcERI alpha
-
GARMAN SC, WURZBURG BA, TARCHEVSKAYA SS, KINET JP, JARDETZKY TS: Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcERI alpha. Nature (2000) 406(6793):259-266.
-
(2000)
Nature
, vol.406
, Issue.6793
, pp. 259-266
-
-
Garman, S.C.1
Wurzburg, B.A.2
Tarchevskaya, S.S.3
Kinet, J.P.4
Jardetzky, T.S.5
-
23
-
-
0037497304
-
Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc
-
HERR AB, BALLISTER ER, BJORKMAN PJ: Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc. Nature (2003) 423 6940):614-620.
-
(2003)
Nature
, vol.423
, Issue.6940
, pp. 614-620
-
-
Herr, A.B.1
Ballister, E.R.2
Bjorkman, P.J.3
-
24
-
-
0035844212
-
The structure of a human Type III Fcγ receptor in complex with Fc
-
RADAEV S, MOTYKA S, FRIDMAN WH, SAUTES-FRIDMAN C, SUN PD: The structure of a human Type III Fcγ receptor in complex with Fc. J. Biol. Chem. (2001) 276(19):16469-16477.
-
(2001)
J. Biol. Chem.
, vol.276
, Issue.19
, pp. 16469-16477
-
-
Radaev, S.1
Motyka, S.2
Fridman, W.H.3
Sautes-Fridman, C.4
Sun, P.D.5
-
25
-
-
1142298744
-
Human antibody-Fc receptor interactions illuminated by crystal structures
-
WOOF JM, BURTON DR: Human antibody-Fc receptor interactions illuminated by crystal structures. Nat. Rev. Immunol. (2004) 4 2):89-99.
-
(2004)
Nat. Rev. Immunol.
, vol.4
, Issue.2
, pp. 89-99
-
-
Woof, J.M.1
Burton, D.R.2
-
26
-
-
0032937238
-
Crystal structure of the human leukocyte Fc receptor, FcγRIIa
-
MAXWELL KF, POWELL MS, HULETT MD et al.: Crystal structure of the human leukocyte Fc receptor, FcγRIIa. Nat. Struct. Biol. (1999) 6(5):437-442.
-
(1999)
Nat. Struct. Biol.
, vol.6
, Issue.5
, pp. 437-442
-
-
Maxwell, K.F.1
Powell, M.S.2
Hulett, M.D.3
-
27
-
-
0033106166
-
Crystal structure of the soluble form ofthe human Fcγ-receptor IIb: A new member of the immunoglobulin superfamily at 1.7 A resolution
-
SONDERMANN P, HUBER R, JACOB U: Crystal structure of the soluble form ofthe human Fcγ-receptor IIb: a new member of the immunoglobulin superfamily at 1.7 A resolution. EMBO J. (1999) 18(5):1095-1103.
-
(1999)
EMBO J.
, vol.18
, Issue.5
, pp. 1095-1103
-
-
Sondermann, P.1
Huber, R.2
Jacob, U.3
-
28
-
-
0032419721
-
Crystal structure ofthe human high-affinity IgE receptor
-
GARMAN SC, KINET JP, JARDETZKY TS: Crystal structure ofthe human high-affinity IgE receptor. Cell (1998) 95(7):951-961.
-
(1998)
Cell
, vol.95
, Issue.7
, pp. 951-961
-
-
Garman, S.C.1
Kinet, J.P.2
Jardetzky, T.S.3
-
29
-
-
0041344597
-
Crystal structure of the ectodomain of human FcαRI
-
DING Y, XU G, YANG M et al.: Crystal structure of the ectodomain of human FcαRI. J. Biol. Chem. (2003) 278 30):27966-27970.
-
(2003)
J. Biol. Chem.
, vol.278
, Issue.30
, pp. 27966-27970
-
-
Ding, Y.1
Xu, G.2
Yang, M.3
-
30
-
-
0041381311
-
Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor
-
WILLCOX BE, THOMAS LM, BJORKMAN PJ: Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. (2003) 4(9):913-919.
-
(2003)
Nat. Immunol.
, vol.4
, Issue.9
, pp. 913-919
-
-
Willcox, B.E.1
Thomas, L.M.2
Bjorkman, P.J.3
-
31
-
-
0033636273
-
Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2)
-
CHAPMAN TL, HEIKEMA AP, WEST AP, BJOEKMAN PJ: Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2) Immunity (2000) 13 5):727-736.
-
(2000)
Immunity
, vol.13
, Issue.5
, pp. 727-736
-
-
Chapman, T.L.1
Heikema, A.P.2
West, A.P.3
Bjoekman, P.J.4
-
32
-
-
0028239549
-
Physical and functional association of Src-related protein tyrosine kinases with FcγRII in monocytic THP-1 cells
-
GHAZIZADEH S, BOLEN JB, FLEIT HB: Physical and functional association of Src-related protein tyrosine kinases with FcγRII in monocytic THP-1 cells. J. Biol. Chem. (1994) 269 12):8878-8884.
-
(1994)
J. Biol. Chem.
, vol.269
, Issue.12
, pp. 8878-8884
-
-
Ghazizadeh, S.1
Bolen, J.B.2
Fleit, H.B.3
-
33
-
-
0028106837
-
Physical and functional association of the high affinity immunoglobulin G receptor (FcγRI) with the kinases Hck and Lyn
-
WANG AV, SCHOLL PR, GEHA RS: Physical and functional association of the high affinity immunoglobulin G receptor (FcγRI) with the kinases Hck and Lyn. J. Exp. Med. (1994) 180 3):1165-1170.
-
(1994)
J. Exp. Med.
, vol.180
, Issue.3
, pp. 1165-1170
-
-
Wang, A.V.1
Scholl, P.R.2
Geha, R.S.3
-
34
-
-
0032055485
-
SHIP modulates immune receptor responses by regulating membrane association of Btk
-
BOLLAND S, PEARSE RN, KUROSAKI T, RAVETCH JV: SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity (1998) 8(4):509-516.
-
(1998)
Immunity
, vol.8
, Issue.4
, pp. 509-516
-
-
Bolland, S.1
Pearse, R.N.2
Kurosaki, T.3
Ravetch, J.V.4
-
35
-
-
0032055476
-
2+ following B-cell receptor activation
-
2+ following B-cell receptor activation. EMBO J. (1998) 17(7):1973-1985.
-
(1998)
EMBO J.
, vol.17
, Issue.7
, pp. 1973-1985
-
-
Fluckiger, A.C.1
Li, Z.2
Kato, R.M.3
-
36
-
-
0032055484
-
Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: A target for SHIP-mediated inhibitory signals
-
SCHARENBERG AM, EL-HILLAL O, FRUMAN DA et al.: Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. (1998) 17(7):1961-1672.
-
(1998)
EMBO J.
, vol.17
, Issue.7
, pp. 1672-1961
-
-
Scharenberg, A.M.1
El-Hillal, O.2
Fruman, D.A.3
-
37
-
-
0033710778
-
The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells
-
TAMIR I, STOLPA JC, HELGASON CD et al.: The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity (2000) 12(3):347-358.
-
(2000)
Immunity
, vol.12
, Issue.3
, pp. 347-358
-
-
Tamir, I.1
Stolpa, J.C.2
Helgason, C.D.3
-
38
-
-
0030031886
-
Augmented humoral and anaphylactic responses in FcγRII-deficient mice
-
TAKAI T, ONO M, HIKIDA M, OHOMORI H, RAVETCH JV: Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature (1996) 379(6563):346-349.
-
(1996)
Nature
, vol.379
, Issue.6563
, pp. 346-349
-
-
Takai, T.1
Ono, M.2
Hikida, M.3
Ohomori, H.4
Ravetch, J.V.5
-
39
-
-
0033151596
-
SHIP recruitment attenuates FcγRIIB-induced B cell apoptosis
-
PEARSE RN, KAWABE T, BOLLAND S, GUINAMARD R, KUROSKI T, RAVETCH JV: SHIP recruitment attenuates FcγRIIB-induced B cell apoptosis. Immunity (1999) 10(6):753-760.
-
(1999)
Immunity
, vol.10
, Issue.6
, pp. 753-760
-
-
Pearse, R.N.1
Kawabe, T.2
Bolland, S.3
Guinamard, R.4
Kuroski, T.5
Ravetch, J.V.6
-
40
-
-
0034102982
-
Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility
-
JIANG Y, HIROSE S, ABE M et al.: Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics (2000) 51(6):429-435.
-
(2000)
Immunogenetics
, vol.51
, Issue.6
, pp. 429-435
-
-
Jiang, Y.1
Hirose, S.2
Abe, M.3
-
41
-
-
0037108491
-
Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses
-
XIU Y, NAKAMURA K, ABE M et al.: Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J. Immunol. (2002) 169 8):4340-4346.
-
(2002)
J. Immunol.
, vol.169
, Issue.8
, pp. 4340-4346
-
-
Xiu, Y.1
Nakamura, K.2
Abe, M.3
-
42
-
-
0036780841
-
Regulation of mast-cell and basophil function and survival by IgE
-
KAWAKAMI T, GALLI SJ: Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. (2002) 2 10):773-786.
-
(2002)
Nat. Rev. Immunol.
, vol.2
, Issue.10
, pp. 773-786
-
-
Kawakami, T.1
Galli, S.J.2
-
43
-
-
1942499587
-
Fcγ receptors on mast cells: Activating and inhibitory regulation of mediator release
-
TRACZYK C, OKAYAMA Y, METCALFE DD, GLIFILLAN AM: Fcγ receptors on mast cells: activating and inhibitory regulation of mediator release. Int. Arch. Allergy Immunol. (2004) 133(3):305-315.
-
(2004)
Int. Arch. Allergy Immunol.
, vol.133
, Issue.3
, pp. 305-315
-
-
Traczyk, C.1
Okayama, Y.2
Metcalfe, D.D.3
Glifillan, A.M.4
-
44
-
-
0028035310
-
Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation
-
PRIBLUDA VS, PRIBLUDA C, METZGER H: Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation. Proc. Natl. Acad. Sci. USA (1994) 91(23):11246-11250.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, Issue.23
, pp. 11246-11250
-
-
Pribluda, V.S.1
Pribluda, C.2
Metzger, H.3
-
45
-
-
0031042637
-
Syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction
-
EL-HILLAL O, KUROSAKI T, YAMAMURA H, KINET JP, SCHARENBERG AM: Syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction. Proc. Natl. Acad. Sci. USA (1997) 94(5):1919-1924.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, Issue.5
, pp. 1919-1924
-
-
El-Hillal, O.1
Kurosaki, T.2
Yamamura, H.3
Kinet, J.P.4
Scharenberg, A.M.5
-
46
-
-
0033678973
-
LAT is essential for FcERI-mediated mast cell activation
-
SAITOH S, ARUDCHANDRAN R, MANETZ TS et al.: LAT is essential for FcERI-mediated mast cell activation. Immunity (2000) 12(5):525-535.
-
(2000)
Immunity
, vol.12
, Issue.5
, pp. 525-535
-
-
Saitoh, S.1
Arudchandran, R.2
Manetz, T.S.3
-
48
-
-
0032238298
-
Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation
-
GU H, PRATT JC, BURAKOFF SJ, NEEL BG: Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol. Cell. (1998) 2(6):729-740
-
(1998)
Mol. Cell.
, vol.2
, Issue.6
, pp. 729-740
-
-
Gu, H.1
Pratt, J.C.2
Burakoff, S.J.3
Neel, B.G.4
-
49
-
-
0036347746
-
Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation
-
PARRAVICINI V, GADINA M, KOVAROVA M et al.: Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. (2002) 3(8):741-748.
-
(2002)
Nat. Immunol.
, vol.3
, Issue.8
, pp. 741-748
-
-
Parravicini, V.1
Gadina, M.2
Kovarova, M.3
-
50
-
-
0141483031
-
Role of phosphoinositide 3-kinase signaling in mast cells: New insights from knockout mouse studies
-
FUKAO T, TERAUCHI Y, KADOWAKI T, KOYASU S: Role of phosphoinositide 3-kinase signaling in mast cells: new insights from knockout mouse studies. J. Mol. Med. (2003) 81(9):524-535.
-
(2003)
J. Mol. Med.
, vol.81
, Issue.9
, pp. 524-535
-
-
Fukao, T.1
Terauchi, Y.2
Kadowaki, T.3
Koyasu, S.4
-
51
-
-
0036032969
-
FcERI signaling observed from the inside of the mast cell membrane
-
WILSON BS, PFEIFFER JR, OLIVER JM: FcERI signaling observed from the inside of the mast cell membrane. Mol. Immunol. (2002) 38(16-18):1259-1268.
-
(2002)
Mol. Immunol.
, vol.38
, Issue.16-18
, pp. 1259-1268
-
-
Wilson, B.S.1
Pfeiffer, J.R.2
Oliver, J.M.3
-
52
-
-
0036909507
-
Signal transduction during Fc receptor-mediated phagocytosis
-
GARCIA-GARCIA E, ROSALES C: Signal transduction during Fc receptor-mediated phagocytosis. J. Leukoc. Biol. (2002) 72 6):1092-1108.
-
(2002)
J. Leukoc. Biol.
, vol.72
, Issue.6
, pp. 1092-1108
-
-
Garcia-Garcia, E.1
Rosales, C.2
-
53
-
-
0035205569
-
Phagocytic signaling strategies: Fcγ receptor-mediated phagocytosis as a model system
-
COX D, GREENBERG S: Phagocytic signaling strategies: Fcγ receptor-mediated phagocytosis as a model system. Semin. Immunol. (2001) 13(6):339-345.
-
(2001)
Semin. Immunol.
, vol.13
, Issue.6
, pp. 339-345
-
-
Cox, D.1
Greenberg, S.2
-
54
-
-
0028042424
-
FcRγ chain deletion results in pleiotrophic effector cell defects
-
TAKAI T, LI M, SYLVESTRE D, CLYNES R, RAVETCH JV: FcRγ chain deletion results in pleiotrophic effector cell defects. Cell (1994) 76(3):519-529.
-
(1994)
Cell
, vol.76
, Issue.3
, pp. 519-529
-
-
Takai, T.1
Li, M.2
Sylvestre, D.3
Clynes, R.4
Ravetch, J.V.5
-
55
-
-
0034695748
-
Fc receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr and Lyn
-
FITZER-ATTAS CJ, CROWLEY MT, FINN AJ, MENG F, DEFRANCO AL, LOWELL CA: Fc receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr and Lyn. J. Exp. Med. (2000) 191(4):669-682.
-
(2000)
J. Exp. Med.
, vol.191
, Issue.4
, pp. 669-682
-
-
Fitzer-Attas, C.J.1
Crowley, M.T.2
Finn, A.J.3
Meng, F.4
Defranco, A.L.5
Lowell, C.A.6
-
56
-
-
0030829551
-
A critical role for Syk in signal transduction and phagocytosis mediated by Fc receptors on macrophages
-
CROWLEY MT, COSTELLO PS, FITZER-ATTAS CJ et al.: A critical role for Syk in signal transduction and phagocytosis mediated by Fc receptors on macrophages. J. Exp. Med. (1997) 186 7):1027-1039.
-
(1997)
J. Exp. Med.
, vol.186
, Issue.7
, pp. 1027-1039
-
-
Crowley, M.T.1
Costello, P.S.2
Fitzer-Attas, C.J.3
-
57
-
-
0031807018
-
The Syk protein tyrosine kinase is essential for Fc receptor signaling in macrophages and neutrophils
-
KIEFER F, BRUMELL J, AL-ALAWII N et al.: The Syk protein tyrosine kinase is essential for Fc receptor signaling in macrophages and neutrophils. Mol. Cell Biol. (1998) 18 7):4209-4220.
-
(1998)
Mol. Cell Biol.
, vol.18
, Issue.7
, pp. 4209-4220
-
-
Kiefer, F.1
Brumell, J.2
Al-Alawii, N.3
-
58
-
-
0033068059
-
Protein kinase C and a calcium-independent phospholipase are required for IgG-mediated phagocytosis by Mono-Mac-6 cells
-
KARIMI K, GEMMILL TR, LENNARTZ MR: Protein kinase C and a calcium-independent phospholipase are required for IgG-mediated phagocytosis by Mono-Mac-6 cells. J. Leukoc. Biol. (1999) 65 6):854-862.
-
(1999)
J. Leukoc. Biol.
, vol.65
, Issue.6
, pp. 854-862
-
-
Karimi, K.1
Gemmill, T.R.2
Lennartz, M.R.3
-
59
-
-
0034710805
-
Protein kinase C-α participates in FcγR-mediated phagocytosis in macrophages
-
BRETON A, DESCOTEAUX A: Protein kinase C-α participates in FcγR-mediated phagocytosis in macrophages. Biochem. Biophys. Res. Commun. (2000) 276(2):472-476.
-
(2000)
Biochem. Biophys. Res. Commun.
, vol.276
, Issue.2
, pp. 472-476
-
-
Breton, A.1
Descoteaux, A.2
-
60
-
-
0034725039
-
The requirement of both extracellular regulated kinase and p38 mitogen-activated protein kinase for stimulation of cytosolic phospholipase A(2) activity by either FcγRIIA or FcγRIIIB in human neutrophils. A possible role for Pyk2 but not for the Grb2-Sos-Shc complex
-
HAZAN-HALEVY I, SWGER R, LEVY R: The requirement of both extracellular regulated kinase and p38 mitogen-activated protein kinase for stimulation of cytosolic phospholipase A(2) activity by either FcγRIIA or FcγRIIIB in human neutrophils. A possible role for Pyk2 but not for the Grb2-Sos-Shc complex. J. Biol. Chem. (2000) 275 17):12416-12423.
-
(2000)
J. Biol. Chem.
, vol.275
, Issue.17
, pp. 12416-12423
-
-
Hazan-Halevy, I.1
Swger, R.2
Levy, R.3
-
61
-
-
0034739859
-
Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis
-
BOTELHO RJ, TERUEL M, DIERCKMAN R et al.: Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J. Cell. Biol. (2000) 151(7):1353-1368.
-
(2000)
J. Cell. Biol.
, vol.151
, Issue.7
, pp. 1353-1368
-
-
Botelho, R.J.1
Teruel, M.2
Dierckman, R.3
-
62
-
-
0033558080
-
Fcγ receptor-mediated activation of phospholipase D regulates macrophage phagocytosis of IgG-opsonized particles
-
KUSNER DJ, HALL CF, JACKSON S: Fcγ receptor-mediated activation of phospholipase D regulates macrophage phagocytosis of IgG-opsonized particles. J. Immunol. (1999) 162(4):2266-2274.
-
(1999)
J. Immunol.
, vol.162
, Issue.4
, pp. 2266-2274
-
-
Kusner, D.J.1
Hall, C.F.2
Jackson, S.3
-
63
-
-
0141532180
-
Class I phosphoinositide 3-kinase p110β is required for apoptotic cell and Fcγ receptor-mediated phagocytosis by macrophages
-
LEVERRIER Y, OKKENHAUG K, SAWYER C, BILANCIO A, VANHAESEBROECK B, RIDLEY AJ: Class I phosphoinositide 3-kinase p110β is required for apoptotic cell and Fcγ receptor-mediated phagocytosis by macrophages. J. Biol. Chem. (2003) 278(40):38437-38442.
-
(2003)
J. Biol. Chem.
, vol.278
, Issue.40
, pp. 38437-38442
-
-
Leverrier, Y.1
Okkenhaug, K.2
Sawyer, C.3
Bilancio, A.4
Vanhaesebroeck, B.5
Ridley, A.J.6
-
64
-
-
2642518949
-
Fcγ receptor signaling in primary human microglia: Differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction
-
SONG X, TANAKA S, COX D, LEE SC: Fcγ receptor signaling in primary human microglia: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction. J. Leukoc. Biol. (2004) 75(6):1147-1155.
-
(2004)
J. Leukoc. Biol.
, vol.75
, Issue.6
, pp. 1147-1155
-
-
Song, X.1
Tanaka, S.2
Cox, D.3
Lee, S.C.4
-
66
-
-
0029026704
-
2+ accumulation in Fcγ-receptor-mediated phagocytosis of human neutrophils
-
2+ accumulation in Fcγ-receptor-mediated phagocytosis of human neutrophils. J. Biochem. (1995) 117 6):1156-1161.
-
(1995)
J. Biochem.
, vol.117
, Issue.6
, pp. 1156-1161
-
-
Kobayashi, K.1
Takahashi, K.2
Nagasawa, S.3
-
67
-
-
0034306013
-
Function of Rho family proteins in actin dynamics during phagocytosis and engulfment
-
CHIMINI G, CHAVRIER P: Function of Rho family proteins in actin dynamics during phagocytosis and engulfment. Nat. Cell. Biol. (2000) 2(10):E191-E196.
-
(2000)
Nat. Cell. Biol.
, vol.2
, Issue.10
-
-
Chimini, G.1
Chavrier, P.2
-
68
-
-
0036175145
-
Dynamics of cytoskeletal proteins during Fcγ receptor-mediated phagocytosis in macrophages
-
DIAKONOVA M, BOKOCH G, SWANSON JA: Dynamics of cytoskeletal proteins during Fcγ receptor-mediated phagocytosis in macrophages. Mol. Biol. Cell. (2002) 13(2):402-411.
-
(2002)
Mol. Biol. Cell.
, vol.13
, Issue.2
, pp. 402-411
-
-
Diakonova, M.1
Bokoch, G.2
Swanson, J.A.3
-
69
-
-
0035954430
-
Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fcγ receptor-mediated phagocytosis
-
MARSHALL JG, BOOTH JW, STAMBOLIC V et al.: Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fcγ receptor-mediated phagocytosis. J. Cell. Biol. (2001) 153(7):1369-1380.
-
(2001)
J. Cell. Biol.
, vol.153
, Issue.7
, pp. 1369-1380
-
-
Marshall, J.G.1
Booth, J.W.2
Stambolic, V.3
-
70
-
-
0035494493
-
Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation
-
VIEIRA OV, BOTELHO RJ, RAMEH L et al.: Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. J. Cell. Biol. (2001) 155(1):19-25.
-
(2001)
J. Cell. Biol.
, vol.155
, Issue.1
, pp. 19-25
-
-
Vieira, O.V.1
Botelho, R.J.2
Rameh, L.3
-
71
-
-
0038491474
-
Critical role for scaffolding adapter Gab2 in FcγR-mediated phagocytosis
-
GU H, BOTELHO RJ, YU M, GRINSTEIN S, NEEL BG: Critical role for scaffolding adapter Gab2 in FcγR-mediated phagocytosis. J. Cell. Biol. (2003) 161(6):1151-1161.
-
(2003)
J. Cell. Biol.
, vol.161
, Issue.6
, pp. 1151-1161
-
-
Gu, H.1
Botelho, R.J.2
Yu, M.3
Grinstein, S.4
Neel, B.G.5
-
72
-
-
0142151094
-
The inhibitory receptor FcγRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcγRI/III but also by efficient clearance and endocytosis of immune complexes
-
VAN LENT P, NABBE KC, BOROSS P et al.: The inhibitory receptor FcγRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcγRI/III but also by efficient clearance and endocytosis of immune complexes. Am. J. Pathol. (2003) 163(5):1839-1848.
-
(2003)
Am. J. Pathol.
, vol.163
, Issue.5
, pp. 1839-1848
-
-
Van Lent, P.1
Nabbe, K.C.2
Boross, P.3
-
73
-
-
0028786994
-
Implicating a role for immune recognition of self in tumor rejection: Passive immunization against the brown locus protein
-
HARA I, TAKECHI Y, HOUGHTON AN: Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. J. Exp. Med. (1995) 182(5):1609-1614.
-
(1995)
J. Exp. Med.
, vol.182
, Issue.5
, pp. 1609-1614
-
-
Hara, I.1
Takechi, Y.2
Houghton, A.N.3
-
74
-
-
0031905710
-
Fc receptors are required in passive and active immunity to melanoma
-
CLYNES R, TAKEUCHI Y, MOROI Y, HOUGHTON A, RAVETCH JV: Fc receptors are required in passive and active immunity to melanoma. Proc. Natl. Acad. Sci. USA (1998) 95(2):652-656.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, Issue.2
, pp. 652-656
-
-
Clynes, R.1
Takeuchi, Y.2
Moroi, Y.3
Houghton, A.4
Ravetch, J.V.5
-
75
-
-
0034076307
-
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
-
CLYNES RA, TOWERS TL, PRESTA LG, RAVETCH JV: Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat. Med. (2000) 6(4): 443-446.
-
(2000)
Nat. Med.
, vol.6
, Issue.4
, pp. 443-446
-
-
Clynes, R.A.1
Towers, T.L.2
Presta, L.G.3
Ravetch, J.V.4
-
76
-
-
10744220151
-
Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy
-
TAKEDA K, YAMAGUCHI N, AKIBA H et al.: Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy J. Exp. Med. (2004) 199(4):437-448.
-
(2004)
J. Exp. Med.
, vol.199
, Issue.4
, pp. 437-448
-
-
Takeda, K.1
Yamaguchi, N.2
Akiba, H.3
-
77
-
-
0037442125
-
Targeting apoptotic tumor cells to FcγR provides efficient and versatile vaccination against tumors by dendritic cells
-
AKIYAMA K, EBIHARA S, YAD A et al.: Targeting apoptotic tumor cells to FcγR provides efficient and versatile vaccination against tumors by dendritic cells. J. Immunol. (2003) 170 4):1641-1648.
-
(2003)
J. Immunol.
, vol.170
, Issue.4
, pp. 1641-1648
-
-
Akiyama, K.1
Ebihara, S.2
Yad, A.3
-
78
-
-
0345414168
-
Accelerated antigen presentation and elicitation of humoral response in vivo by FcγRIIB- and FcγRI/III-mediated immune complex uptake
-
YADA A, EBIHARA S, MATSUMURA K et al.: Accelerated antigen presentation and elicitation of humoral response in vivo by FcγRIIB- and FcγRI/III-mediated immune complex uptake. Cell. Immunol. (2003) 225(1):21-32.
-
(2003)
Cell. Immunol.
, vol.225
, Issue.1
, pp. 21-32
-
-
Yada, A.1
Ebihara, S.2
Matsumura, K.3
-
79
-
-
0033579698
-
Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization
-
REGNAULT A, LANKAR D, LACABANNE V et al.: Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. (1999) 189 2):371-380.
-
(1999)
J. Exp. Med.
, vol.189
, Issue.2
, pp. 371-380
-
-
Regnault, A.1
Lankar, D.2
Lacabanne, V.3
-
80
-
-
0033203120
-
Selective transport of internalized antigens to the cyrosol for MHC class I presentation in dendritic cells
-
RODRIGUEZ A, REGNAULT A, KLEIJMEER M, RICCIARDI-CASTAGNOLI P, AMIGORENA S: Selective transport of internalized antigens to the cyrosol for MHC class I presentation in dendritic cells. Nat. Cell. Biol. (1999) 1(6):362-368.
-
(1999)
Nat. Cell. Biol.
, vol.1
, Issue.6
, pp. 362-368
-
-
Rodriguez, A.1
Regnault, A.2
Kleijmeer, M.3
Ricciardi-Castagnoli, P.4
Amigorena, S.5
-
81
-
-
0037033448
-
Antitumor monoclonal antibodies enhance cross-presentation of cCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells
-
DHODAPKAR KM, KRASOVSKY J, WILLIAMSON B, DHODAPKAR MV: Antitumor monoclonal antibodies enhance cross-presentation of cCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J. Exp. Med. (2002) 195(1):125-133.
-
(2002)
J. Exp. Med.
, vol.195
, Issue.1
, pp. 125-133
-
-
Dhodapkar, K.M.1
Krasovsky, J.2
Williamson, B.3
Dhodapkar, M.V.4
-
82
-
-
0037124367
-
Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells
-
KALERGIS AM, RAVETCH JV: Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells. J. Exp. Med. (2002) 195(12):1653-1659.
-
(2002)
J. Exp. Med.
, vol.195
, Issue.12
, pp. 1653-1659
-
-
Kalergis, A.M.1
Ravetch, J.V.2
-
83
-
-
0037089544
-
Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells
-
ZUM BUSCHENFELDE CM, HERMANN C, SCHMIDT B, PESCHEL C, BERNHARD H: Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells. Cancer Res. (2002) 62(8):2244-2247.
-
(2002)
Cancer Res.
, vol.62
, Issue.8
, pp. 2244-2247
-
-
Zum Buschenfelde, C.M.1
Hermann, C.2
Schmidt, B.3
Peschel, C.4
Bernhard, H.5
-
84
-
-
0021241263
-
The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains
-
MOSTOV KE, FRIEDLANDER M, BLOBEL G: The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains. Nature (1984) 308(5954):37-43.
-
(1984)
Nature
, vol.308
, Issue.5954
, pp. 37-43
-
-
Mostov, K.E.1
Friedlander, M.2
Blobel, G.3
-
85
-
-
0035920589
-
Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy
-
MOURA IC, CENTELLES MN, ARCOS-FAJARDO M et al.: Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J. Exp. Med. (2001) 194(4):417-425.
-
(2001)
J. Exp. Med.
, vol.194
, Issue.4
, pp. 417-425
-
-
Moura, I.C.1
Centelles, M.N.2
Arcos-Fajardo, M.3
-
86
-
-
0037084066
-
IgG transcytosis and recycling by FcRn expressed in MDCK cells reveals ligand-induced redistribution
-
RAMALINGAM TS, DETMER SA, MARTIN WL, BJORKMAN PJ: IgG transcytosis and recycling by FcRn expressed in MDCK cells reveals ligand-induced redistribution. EMBO J. (2002) 21(4):590-601.
-
(2002)
EMBO J.
, vol.21
, Issue.4
, pp. 590-601
-
-
Ramalingam, T.S.1
Detmer, S.A.2
Martin, W.L.3
Bjorkman, P.J.4
-
87
-
-
2942516894
-
Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells
-
YOSHIDA M, CLAYPOOL SM, WAGNER JS et al.: Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity (2004) 20(6):769-783.
-
(2004)
Immunity
, vol.20
, Issue.6
, pp. 769-783
-
-
Yoshida, M.1
Claypool, S.M.2
Wagner, J.S.3
-
88
-
-
0033679212
-
A second amplifier function for the allergy-associated FcERI-β subunit
-
DONNADIEU E, JOUVIN MH, KINET JP: A second amplifier function for the allergy-associated FcERI-β subunit. Immunity (2000) 12 5):515-523.
-
(2000)
Immunity
, vol.12
, Issue.5
, pp. 515-523
-
-
Donnadieu, E.1
Jouvin, M.H.2
Kinet, J.P.3
-
89
-
-
0038742799
-
Competing functions encoded in the allergy-associated FcERIβ gene
-
DONNADIEU E, JOUVIN MH, RANA S et al.: Competing functions encoded in the allergy-associated FcERIβ gene. Immunity (2003) 18(5):665-674.
-
(2003)
Immunity
, vol.18
, Issue.5
, pp. 665-674
-
-
Donnadieu, E.1
Jouvin, M.H.2
Rana, S.3
-
90
-
-
0034895245
-
Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family
-
TAKAI T, ONO M: Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family. Immunol. Rev. (2001) 181:215-222.
-
(2001)
Immunol. Rev.
, vol.181
, pp. 215-222
-
-
Takai, T.1
Ono, M.2
-
91
-
-
0027729893
-
Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene
-
DOMBROWICZ D, FLAMAND V, BRIGMAN KK, KOLLER BH, KINET JP: Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell (1993) 75 5):969-976.
-
(1993)
Cell
, vol.75
, Issue.5
, pp. 969-976
-
-
Dombrowicz, D.1
Flamand, V.2
Brigman, K.K.3
Koller, B.H.4
Kinet, J.P.5
-
92
-
-
0030615040
-
Absence of FcERIα chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FcERI and FcγRIII for limiting amounts of FcRβ and γ chains
-
DOMBROWICZ D, FLAMAND V, MIYAJIMA I, RAVETCH JV, GALLI SJ, KINET JP: Absence of FcERIα chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FcERI and FcγRIII for limiting amounts of FcRβ and γ chains. J. Clin. Invest. (1997) 99(5):915-925.
-
(1997)
J. Clin. Invest.
, vol.99
, Issue.5
, pp. 915-925
-
-
Dombrowicz, D.1
Flamand, V.2
Miyajima, I.3
Ravetch, J.V.4
Galli, S.J.5
Kinet, J.P.6
-
93
-
-
0033577901
-
Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG
-
UJIKE A, ISHIKAWA Y, ONO M et al.: Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J. Exp. Med. (1999) 189(10):1573-1579.
-
(1999)
J. Exp. Med.
, vol.189
, Issue.10
, pp. 1573-1579
-
-
Ujike, A.1
Ishikawa, Y.2
Ono, M.3
-
94
-
-
18344370440
-
FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection
-
IOAN-FACSINAY A, DE KIMPE SJ, HELLWIG SM et al.: FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity (2002) 16(3):391-402.
-
(2002)
Immunity
, vol.16
, Issue.3
, pp. 391-402
-
-
Ioan-Facsinay, A.1
De Kimpe, S.J.2
Hellwig, S.M.3
-
95
-
-
0028222926
-
Mice deficient in CD23 reveal its modulatory role in IgE production but no role in T and B cell development
-
STIEF A, TEXIDO G, SANSIG G, EIBEL H, LE GROS G, VAN DER PUTTEN H: Mice deficient in CD23 reveal its modulatory role in IgE production but no role in T and B cell development. J. Immunol. (1994) 152(7):3378-3390.
-
(1994)
J. Immunol.
, vol.152
, Issue.7
, pp. 3378-3390
-
-
Stief, A.1
Texido, G.2
Sansig, G.3
Eibel, H.4
Le Gros, G.5
Van Der Putten, H.6
-
96
-
-
0028284181
-
Negative feedback regulation of IgE synthesis by murine CD23
-
YU P, KOSCO-VILBOIS M, RICHARDS M, KOHLER G, LAMERS MC: Negative feedback regulation of IgE synthesis by murine CD23. Nature (1994) 369(6483):753-756.
-
(1994)
Nature
, vol.369
, Issue.6483
, pp. 753-756
-
-
Yu, P.1
Kosco-Vilbois, M.2
Richards, M.3
Kohler, G.4
Lamers, M.C.5
-
97
-
-
0028108063
-
Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses
-
TEXIDO G, EIBEL H, LE GROS G, VAN DER PUTTEN H: Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses. J. Immunol. (1994) 153(7):3028-3042.
-
(1994)
J. Immunol.
, vol.153
, Issue.7
, pp. 3028-3042
-
-
Texido, G.1
Eibel, H.2
Le Gros, G.3
Van Der Putten, H.4
-
99
-
-
0034192427
-
Induction and suppression of collagen-induced arthritis is dependent on distinct Fc receptors
-
KLEINAU S, MARTINSSON P, HEYMAN B: Induction and suppression of collagen-induced arthritis is dependent on distinct Fc receptors. J. Exp. Med. (2000) 191(9):1611-1616.
-
(2000)
J. Exp. Med.
, vol.191
, Issue.9
, pp. 1611-1616
-
-
Kleinau, S.1
Martinsson, P.2
Heyman, B.3
-
100
-
-
0037725010
-
Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in FcγRIIB-deficient mice
-
NAKAMURA A, NUKIWA T, TAKAI T: Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in FcγRIIB-deficient mice. J. Autoimmun. (2003) 20(3):227-236.
-
(2003)
J. Autoimmun.
, vol.20
, Issue.3
, pp. 227-236
-
-
Nakamura, A.1
Nukiwa, T.2
Takai, T.3
-
101
-
-
17944384552
-
Resistance of Fc receptor-deficient mice to fatal glomerulonephritis
-
PARK SY, UEDA S, OHNO H et al.: Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J. Clin. Invest. (1998) 102(6):1229-1238.
-
(1998)
J. Clin. Invest.
, vol.102
, Issue.6
, pp. 1229-1238
-
-
Park, S.Y.1
Ueda, S.2
Ohno, H.3
-
102
-
-
0034002678
-
Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRγ-deficient mice
-
WAKAYAMA H, HASEGAWA Y, KAWABE T et al.: Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRγ-deficient mice. Eur. J. Immunol. (2000) 30 4):1182-1190.
-
(2000)
Eur. J. Immunol.
, vol.30
, Issue.4
, pp. 1182-1190
-
-
Wakayama, H.1
Hasegawa, Y.2
Kawabe, T.3
-
103
-
-
0032512855
-
Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis
-
CLYNES R, DUMITRU C, RAVETCH JV: Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science (1998) 279(5353):1052-1054.
-
(1998)
Science
, vol.279
, Issue.5353
, pp. 1052-1054
-
-
Clynes, R.1
Dumitru, C.2
Ravetch, J.V.3
-
104
-
-
18344365948
-
Arthritis critically dependent on innate immune system players
-
JI H, OHMURA K, MALHMOOD U et al.: Arthritis critically dependent on innate immune system players. Immunity (2002) 16 2):157-168.
-
(2002)
Immunity
, vol.16
, Issue.2
, pp. 157-168
-
-
Ji, H.1
Ohmura, K.2
Malhmood, U.3
-
105
-
-
0037446774
-
Essential role of Fcγ receptors in anti-type II collagen antibody-induced arthritis
-
KAGARI T, TANAKA D, DOI H, SHIMOZATO T: Essential role of Fcγ receptors in anti-type II collagen antibody-induced arthritis. J. Immunol. (2003) 170(8):4318-4324.
-
(2003)
J. Immunol.
, vol.170
, Issue.8
, pp. 4318-4324
-
-
Kagari, T.1
Tanaka, D.2
Doi, H.3
Shimozato, T.4
-
106
-
-
0037089664
-
Arthritogenic monoclonal antibodies from K/BxN mice
-
MACCIONI M, ZEDER-LUTZ G, HUANG H et al.: Arthritogenic monoclonal antibodies from K/BxN mice. J. Exp. Med. (2002) 195 8):1071-1077.
-
(2002)
J. Exp. Med.
, vol.195
, Issue.8
, pp. 1071-1077
-
-
Maccioni, M.1
Zeder-Lutz, G.2
Huang, H.3
-
107
-
-
0036771572
-
Expression of FcγRIII is required for development of collagen-induced arthritis
-
DIAZ DE STAHL T, ANDREN M, MARTINSSON P, VERBEEK JS, KLEINAU S: Expression of FcγRIII is required for development of collagen-induced arthritis. Eur. J. Immunol. (2002) 32(10):2915-2922.
-
(2002)
Eur. J. Immunol.
, vol.32
, Issue.10
, pp. 2915-2922
-
-
Diaz De Stahl, T.1
Andren, M.2
Martinsson, P.3
Verbeek, J.S.4
Kleinau, S.5
-
108
-
-
0032217049
-
FcγRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia
-
MEYER D, SCHILLER C, WESTEMANN J et al.: FcγRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood (1998) 92 11):3997-4002.
-
(1998)
Blood
, vol.92
, Issue.11
, pp. 3997-4002
-
-
Meyer, D.1
Schiller, C.2
Westemann, J.3
-
109
-
-
0031702690
-
Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis
-
SUZUKI Y, SHIRATO I, OKUMURA K et al.: Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int. (1998) 54 4):1166-1174.
-
(1998)
Kidney Int.
, vol.54
, Issue.4
, pp. 1166-1174
-
-
Suzuki, Y.1
Shirato, I.2
Okumura, K.3
-
110
-
-
0033521604
-
Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors
-
CLYNES R, MAIZES JS, GUINAMARD R, ONO M, TAKAI T, RAVETCH JV: Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. (1999) 189(1):179-185.
-
(1999)
J. Exp. Med.
, vol.189
, Issue.1
, pp. 179-185
-
-
Clynes, R.1
Maizes, J.S.2
Guinamard, R.3
Ono, M.4
Takai, T.5
Ravetch, J.V.6
-
111
-
-
0034610854
-
Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with Type IV collagen: A novel murine model for autoimmune glomerular basement membrane disease
-
NAKAMURA A, YUASA T, UJIKE A et al.: Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with Type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J. Exp. Med. (2000) 191(5):899-906.
-
(2000)
J. Exp. Med.
, vol.191
, Issue.5
, pp. 899-906
-
-
Nakamura, A.1
Yuasa, T.2
Ujike, A.3
-
112
-
-
0018830639
-
Immunization against heterologous Type II collagen induces arthritis in mice
-
COURTENAY JS, DALLMAN MJ, DAYAN AD, MARTIN A, MOSEDALE B: Immunization against heterologous Type II collagen induces arthritis in mice. Nature (1980) 283(5748):666-668.
-
(1980)
Nature
, vol.283
, Issue.5748
, pp. 666-668
-
-
Courtenay, J.S.1
Dallman, M.J.2
Dayan, A.D.3
Martin, A.4
Mosedale, B.5
-
113
-
-
0017657009
-
Autoimmunity to Type II collagen an experimental model of arthritis
-
TRENTHAM DE, TOWNES AS, KANG AH: Autoimmunity to Type II collagen an experimental model of arthritis. J. Exp. Med. (1977) 146(3):857-868.
-
(1977)
J. Exp. Med.
, vol.146
, Issue.3
, pp. 857-868
-
-
Trentham, D.E.1
Townes, A.S.2
Kang, A.H.3
-
114
-
-
0019512029
-
Type II collagen induced arthritis in mice. I. Major histocompatibility complex (I-region) linkage and antibody correlates
-
WOOLEY PH, LUTHRA HS, STIART JM, DAVID CS: Type II collagen induced arthritis in mice. I. Major histocompatibility complex (I-region) linkage and antibody correlates. J. Exp. Med. (1981) 154 3):688-700.
-
(1981)
J. Exp. Med.
, vol.154
, Issue.3
, pp. 688-700
-
-
Wooley, P.H.1
Luthra, H.S.2
Stiart, J.M.3
David, C.S.4
-
115
-
-
0033521239
-
Deletion of Fcγ receptor IIB renders H-2b mice susceptible to collagen-induced arthritis
-
YUASA T, KUBO S, YOSHINO T et al.: Deletion of Fcγ receptor IIB renders H-2b mice susceptible to collagen-induced arthritis. J. Exp. Med. (1999) 189(1):187-194.
-
(1999)
J. Exp. Med.
, vol.189
, Issue.1
, pp. 187-194
-
-
Yuasa, T.1
Kubo, S.2
Yoshino, T.3
-
116
-
-
0033695963
-
Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis
-
BOLLAND S, RAVETCH JV: Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis. Immunity (2000) 13(2):277-285.
-
(2000)
Immunity
, vol.13
, Issue.2
, pp. 277-285
-
-
Bolland, S.1
Ravetch, J.V.2
-
117
-
-
0034816964
-
Delineating the genetic basis of systemic lupus erythematosus
-
WAKELAND EK, LIU K, GRAHAM RR, BEHRENS TW: Delineating the genetic basis of systemic lupus erythematosus. Immunity (2001) 15(3):397-408.
-
(2001)
Immunity
, vol.15
, Issue.3
, pp. 397-408
-
-
Wakeland, E.K.1
Liu, K.2
Graham, R.R.3
Behrens, T.W.4
-
118
-
-
0021948204
-
Interaction of mutant lpr gene with background strain influences renal disease
-
KELLY VE, ROTHS JB: Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. (1985) 37(2):220-229.
-
(1985)
Clin. Immunol. Immunopathol.
, vol.37
, Issue.2
, pp. 220-229
-
-
Kelly, V.E.1
Roths, J.B.2
-
119
-
-
0018072901
-
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains
-
ANDREWS BS, EISENBERG RA, THEOFILOPOULOS AN et al.: Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. (1978) 148 5):1198-1215.
-
(1978)
J. Exp. Med.
, vol.148
, Issue.5
, pp. 1198-1215
-
-
Andrews, B.S.1
Eisenberg, R.A.2
Theofilopoulos, A.N.3
-
120
-
-
0037730377
-
FcγRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease
-
YAJIMA K, NAKAMURA A, SUGAHARA A, TAKAI T: FcγRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease. Eur. J. Immunol. (2003) 33 4):1020-1029.
-
(2003)
Eur. J. Immunol.
, vol.33
, Issue.4
, pp. 1020-1029
-
-
Yajima, K.1
Nakamura, A.2
Sugahara, A.3
Takai, T.4
-
121
-
-
0035057371
-
Fc-signalling in the modulation of immune responses by passive antibody
-
SINCLAIR NR: Fc-signalling in the modulation of immune responses by passive antibody. Scand. J. Immunol. (2001) 53 4):322-330.
-
(2001)
Scand. J. Immunol.
, vol.53
, Issue.4
, pp. 322-330
-
-
Sinclair, N.R.1
-
122
-
-
2342424834
-
Fc receptors as potential targets for the treatment of allergy, autoimmune disease and cancer
-
TAKAI T, NAKAMURA A, AKIYAMA K: Fc receptors as potential targets for the treatment of allergy, autoimmune disease and cancer. Curr. Drug. Targets. Immune. Endocr. Metabol. Disord. (2003) 3 3):187-197.
-
(2003)
Curr. Drug Targets Immune Endocr. Metabol. Disord.
, vol.3
, Issue.3
, pp. 187-197
-
-
Takai, T.1
Nakamura, A.2
Akiyama, K.3
-
123
-
-
0032705171
-
Atopic allergy and other hypersensitivities
-
KINET JP: Atopic allergy and other hypersensitivities. Curr. Opin. Immunol. (1999) 11(6):603-605.
-
(1999)
Curr. Opin. Immunol.
, vol.11
, Issue.6
, pp. 603-605
-
-
Kinet, J.P.1
-
124
-
-
1342287014
-
Innovative therapies for asthma: Anti-IgE - The future?
-
WEINBERGER M: Innovative therapies for asthma: anti-IgE - the future? Paediatr. Respir. Rev. (2004) 5(Suppl. A):S115-S118.
-
(2004)
Paediatr. Respir. Rev.
, vol.5
, Issue.SUPPL. A
-
-
Weinberger, M.1
-
125
-
-
0035262324
-
Anti-immunoglobulin E for the treatment of allergic disease
-
BUSSE W, NEAVILLE W: Anti-immunoglobulin E for the treatment of allergic disease. Curr. Opin. Allergy. Clin. Immunol. (2001) 1(1):105-108.
-
(2001)
Curr. Opin. Allergy Clin. Immunol.
, vol.1
, Issue.1
, pp. 105-108
-
-
Busse, W.1
Neaville, W.2
-
126
-
-
0842348085
-
Anti-cytokine Ab immune therapy: Present status and perspectives
-
ZAGURY D, GALLO RC: Anti-cytokine Ab immune therapy: present status and perspectives. Drug Discov. Today (2004) 9 2):72-81.
-
(2004)
Drug Discov. Today
, vol.9
, Issue.2
, pp. 72-81
-
-
Zagury, D.1
Gallo, R.C.2
-
127
-
-
0036883552
-
Molecular aspects of allergy
-
MIESCHER SM, VOGEL M: Molecular aspects of allergy. Mol. Aspects Med. (2002) 23(6):413-462.
-
(2002)
Mol. Aspects Med.
, vol.23
, Issue.6
, pp. 413-462
-
-
Miescher, S.M.1
Vogel, M.2
-
128
-
-
0035973343
-
Pathways for self-tolerance and the treatment of autoimmune diseases
-
GOODNOW CC: Pathways for self-tolerance and the treatment of autoimmune diseases. Lancet (2001) 357(9274):2115-2121.
-
(2001)
Lancet
, vol.357
, Issue.9274
, pp. 2115-2121
-
-
Goodnow, C.C.1
-
129
-
-
2342523339
-
Autoantibodies as predictors of disease
-
SCOFIELD RH: Autoantibodies as predictors of disease. Lancet (2004) 363(9420):1544-1546.
-
(2004)
Lancet
, vol.363
, Issue.9420
, pp. 1544-1546
-
-
Scofield, R.H.1
-
130
-
-
2442590862
-
New drugs for rheumatoid arthritis
-
OLSENI NJ, STEIN CM: New drugs for rheumatoid arthritis. N. Engl. J. Med. (2004) 350(21):2167-2179.
-
(2004)
N. Engl. J. Med.
, vol.350
, Issue.21
, pp. 2167-2179
-
-
Olseni, N.J.1
Stein, C.M.2
-
132
-
-
0035056003
-
Anti-TNF-α therapy of rheumatoid arthritis: What have we learned?
-
FELDMANN M, MAINI RN: Anti-TNF-α therapy of rheumatoid arthritis: what have we learned? Ann. Rev. Immunol. (2001) 19 163-196.
-
(2001)
Ann. Rev. Immunol.
, vol.19
, pp. 163-196
-
-
Feldmann, M.1
Maini, R.N.2
-
133
-
-
0029617952
-
Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-α antibody with the interleukin-1 receptor antagonist
-
BUTLER DM, MAINI RN, FELDMANN M, BRENNAN FM: Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-α antibody with the interleukin-1 receptor antagonist. Eur. Cytokine. Netw. (1995) 6 4):225-230.
-
(1995)
Eur. Cytokine Netw.
, vol.6
, Issue.4
, pp. 225-230
-
-
Butler, D.M.1
Maini, R.N.2
Feldmann, M.3
Brennan, F.M.4
-
134
-
-
0036899812
-
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double-blind, placebo-controlled, dose-escalation trial
-
CHOY EH, ISENBERG DA, GARROOD T et al.: Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis. Rheum. (2002) 46(12):3143-3150.
-
(2002)
Arthritis Rheum.
, vol.46
, Issue.12
, pp. 3143-3150
-
-
Choy, E.H.1
Isenberg, D.A.2
Garrood, T.3
-
135
-
-
2642558925
-
Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial
-
NISHIMOTO N, YOSHIZAKI K, MIYASAKA N et al.: Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis. Rheum. (2004) 50(6):1761-1769.
-
(2004)
Arthritis Rheum.
, vol.50
, Issue.6
, pp. 1761-1769
-
-
Nishimoto, N.1
Yoshizaki, K.2
Miyasaka, N.3
-
136
-
-
0347519211
-
B cell activation in rheumatoid arthritis patients under infliximab treatment
-
DE MIGUEL S, JOVER JA, VADILLO C, JUDEZ E, LOZA E, FERNANDEZ-GUTIERREZ B: B cell activation in rheumatoid arthritis patients under infliximab treatment. Clin. Exp. Rheumatol. (2003) 21 6):726-732.
-
(2003)
Clin. Exp. Rheumatol.
, vol.21
, Issue.6
, pp. 726-732
-
-
De Miguel, S.1
Jover, J.A.2
Vadillo, C.3
Judez, E.4
Loza, E.5
Fernandez-Gutierrez, B.6
-
137
-
-
0029862164
-
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes
-
KOSHY M, BERGER D, CROW MK: Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. (1996) 98(3):826-837.
-
(1996)
J. Clin. Invest.
, vol.98
, Issue.3
, pp. 826-837
-
-
Koshy, M.1
Berger, D.2
Crow, M.K.3
-
138
-
-
0029913381
-
Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production
-
DESAI-MEHTA A, LU L, RAMSEY-GOLDMANOL R, DATTA SK: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. (1996) 97(9):2063-2073.
-
(1996)
J. Clin. Invest.
, vol.97
, Issue.9
, pp. 2063-2073
-
-
Desai-Mehta, A.1
Lu, L.2
Ramsey-Goldmanol, R.3
Datta, S.K.4
-
139
-
-
0032742987
-
The soluble CD40 ligand sCD154 in systemic lupus erythematosus
-
KATO K, SANTANA-SAHAGÚN E, RASSENTI L Z et al.: The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J. Clin. Invest. (1999) 104(7):947-955.
-
(1999)
J. Clin. Invest.
, vol.104
, Issue.7
, pp. 947-955
-
-
Kato, K.1
Santana-Sahagún, E.2
Rassenti, L.Z.3
-
140
-
-
0345824714
-
Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions
-
GRAMMER AC, SLOTA R, FISHER R et al.: Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J. Clin. Invest. (2003) 112 10):1506-1520.
-
(2003)
J. Clin. Invest.
, vol.112
, Issue.10
, pp. 1506-1520
-
-
Grammer, A.C.1
Slota, R.2
Fisher, R.3
-
141
-
-
0036899589
-
Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD 154: A randomized, double-blind, placebo-controlled trial
-
IDEC-131 Lupus Study Group
-
KALUNIAN KC, DAVIS JC Jr, MERRILL JT, TOTORITIS MC, WOFSY D: IDEC-131 Lupus Study Group. Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD 154: a randomized, double-blind, placebo-controlled trial. Arthritis. Rheum. (2002) 46(12):3251-3258.
-
(2002)
Arthritis Rheum.
, vol.4
, Issue.612
, pp. 3251-3258
-
-
Kalunian, K.C.1
Davis Jr., J.C.2
Merrill, J.T.3
Totoritis, M.C.4
Wofsy, D.5
-
142
-
-
0033965079
-
Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
-
KAWAI T, ANDREWS D, COLVIN RB, SACHS DH, COSIMI AB: Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat. Med. (2000) 6(2):114.
-
(2000)
Nat. Med.
, vol.6
, Issue.2
, pp. 114
-
-
Kawai, T.1
Andrews, D.2
Colvin, R.B.3
Sachs, D.H.4
Cosimi, A.B.5
-
144
-
-
0036822286
-
An open study of B lymphocyte depletion in systemic lupus erythematosus
-
LEANDRO MJ, EDWARDS JC, CAMBRIDGE G, EHRENSTEIN MR, ISENBERG DA: An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis. Rheum. (2002) 46(10):2673-2677.
-
(2002)
Arthritis Rheum.
, vol.46
, Issue.10
, pp. 2673-2677
-
-
Leandro, M.J.1
Edwards, J.C.2
Cambridge, G.3
Ehrenstein, M.R.4
Isenberg, D.A.5
-
145
-
-
2942537697
-
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
-
EDWARDS JC, SZCZEPANSKI L, SZECHINSKI J et al.: Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. (2004) 350 25):2572-2581.
-
(2004)
N. Engl. J. Med.
, vol.350
, Issue.25
, pp. 2572-2581
-
-
Edwards, J.C.1
Szczepanski, L.2
Szechinski, J.3
-
146
-
-
0033230622
-
Clinical applications of anti-CD20 antibodies
-
GOPAL AK, PRESS OW. Clinical applications of anti-CD20 antibodies. J. Lab. Clin. Med. (1999) 134(5):445-450.
-
(1999)
J. Lab. Clin. Med.
, vol.134
, Issue.5
, pp. 445-450
-
-
Gopal, A.K.1
Press, O.W.2
-
147
-
-
3042592452
-
The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy
-
UCHIDA J, HAMAGUCHI Y, OLIVER JA et al.: The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J. Exp. Med. (2004) 199(12):1659-6169.
-
(2004)
J. Exp. Med.
, vol.199
, Issue.12
, pp. 1659-6169
-
-
Uchida, J.1
Hamaguchi, Y.2
Oliver, J.A.3
-
148
-
-
0037289807
-
The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus
-
ANOLIK JH, CAMPBELL D, FELGAR RE et al.: The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis. Rheum. (2003) 48(2):455-459.
-
(2003)
Arthritis Rheum.
, vol.48
, Issue.2
, pp. 455-459
-
-
Anolik, J.H.1
Campbell, D.2
Felgar, R.E.3
-
149
-
-
1542358942
-
Rituximab: Expanding role in therapy for lymphomas and autoimmune diseases
-
RASTETTER W, MOLINA A, WHITE CA: Rituximab: expanding role in therapy for lymphomas and autoimmune diseases. Ann. Rev. Med. (2004) 55:477-503.
-
(2004)
Ann. Rev. Med.
, vol.55
, pp. 477-503
-
-
Rastetter, W.1
Molina, A.2
White, C.A.3
-
150
-
-
0033855859
-
Clinical trials of antibody therapy
-
GLENNIE MJ, JOHNSON PW: Clinical trials of antibody therapy. Immunol. Today (2000) 21(8):403-410.
-
(2000)
Immunol. Today
, vol.21
, Issue.8
, pp. 403-410
-
-
Glennie, M.J.1
Johnson, P.W.2
-
151
-
-
1342345215
-
Complement function in mAb-mediated cancer immunotherapy
-
GELDERMAN KA, TOMLINSON S, ROSS GD, GORTER A: Complement function in mAb-mediated cancer immunotherapy. Trends Immunol. (2004) 25(3):158-164.
-
(2004)
Trends Immunol.
, vol.25
, Issue.3
, pp. 158-164
-
-
Gelderman, K.A.1
Tomlinson, S.2
Ross, G.D.3
Gorter, A.4
-
152
-
-
2142714017
-
Monoclonal antibodies as therapeutic agents for cancer
-
HARRIS M: Monoclonal antibodies as therapeutic agents for cancer. Lancet Oncol. (2004) 5(5):292-302.
-
(2004)
Lancet Oncol.
, vol.5
, Issue.5
, pp. 292-302
-
-
Harris, M.1
-
153
-
-
0021272605
-
Expression of human B cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation
-
ANDERSON K, BATES M, SLAUGHENHOUPT B, PINKUS GS, SCHLOSSMAN SF, NADLER LM: Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood (1984) 63(6):1424-1433.
-
(1984)
Blood
, vol.63
, Issue.6
, pp. 1424-1433
-
-
Anderson, K.1
Bates, M.2
Slaughenhoupt, B.3
Pinkus, G.S.4
Schlossman, S.F.5
Nadler, L.M.6
-
154
-
-
0038014070
-
Randomized Phase III study for the treatment of advanced indolent non-Hodgkids lymphomas (NHL) and mantle cell lymphoma: Chemotherapy versus chemotherapy plus rituximab
-
HEROLD M, DOLKEN G, FIEDLER F et al.: Randomized Phase III study for the treatment of advanced indolent non-Hodgkids lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab. Ann. Hematol. (2003) 82(2):77-79.
-
(2003)
Ann. Hematol.
, vol.82
, Issue.2
, pp. 77-79
-
-
Herold, M.1
Dolken, G.2
Fiedler, F.3
-
155
-
-
0036464719
-
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
-
CARTRON G, DACHEUX L, SALLES G et al.: Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene. Blood (2002) 99(3):754-758.
-
(2002)
Blood
, vol.99
, Issue.3
, pp. 754-758
-
-
Cartron, G.1
Dacheux, L.2
Salles, G.3
-
156
-
-
0037092951
-
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: Results of a large international study
-
KEATING MJ, FLINN I, JAIN V et al.: Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood (2002) 99 10):3554-3561.
-
(2002)
Blood
, vol.99
, Issue.10
, pp. 3554-3561
-
-
Keating, M.J.1
Flinn, I.2
Jain, V.3
-
157
-
-
0141885088
-
Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H
-
ZHANG Z, ZHANG M, GOLDMAN CK, RAVETCH JV, WALDMANN TA: Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H. Cancer. Res. (2003) 63(19):6453-6457.
-
(2003)
Cancer Res.
, vol.63
, Issue.19
, pp. 6453-6457
-
-
Zhang, Z.1
Zhang, M.2
Goldman, C.K.3
Ravetch, J.V.4
Waldmann, T.A.5
-
158
-
-
0024337144
-
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
-
SLAMONI DJ, GODOLPHIN W, JONES LA et al.: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (1989) 244(4905):707-712.
-
(1989)
Science
, vol.244
, Issue.4905
, pp. 707-712
-
-
Slamoni, D.J.1
Godolphin, W.2
Jones, L.A.3
-
159
-
-
3042611780
-
Oncogenic growth factor receptors: Implications for signal transduction therapy
-
MOSESSON Y, YARDEN Y. Oncogenic growth factor receptors: implications for signal transduction therapy. Semin. Cancer Biol. (2004) 14(4):262-270.
-
(2004)
Semin. Cancer Biol.
, vol.14
, Issue.4
, pp. 262-270
-
-
Mosesson, Y.1
Yarden, Y.2
-
160
-
-
0032851961
-
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)
-
SLIWKOWSKI MX, LOFGREN JA, LEWIS GD, HOTALING TE, FENDLY BM, FOX JA: Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). Semin. Oncol. (1999) 4(Suppl. 12):60-70.
-
(1999)
Semin. Oncol.
, vol.4
, Issue.SUPPL. 12
, pp. 60-70
-
-
Sliwkowski, M.X.1
Lofgren, J.A.2
Lewis, G.D.3
Hotaling, T.E.4
Fendly, B.M.5
Fox, J.A.6
-
161
-
-
1842426004
-
Trastuzumab (Herceptin) enhances class I-restricted antigen presentation recognized by HER-2/neu-specific T cytotoxic lymphocytes
-
KONO K, SATO E, NAGANUMA H et al.: Trastuzumab (Herceptin) enhances class I-restricted antigen presentation recognized by HER-2/neu-specific T cytotoxic lymphocytes. Clin. Cancer. Res. (2004) 10(7):2538-2544.
-
(2004)
Clin. Cancer Res.
, vol.10
, Issue.7
, pp. 2538-2544
-
-
Kono, K.1
Sato, E.2
Naganuma, H.3
-
163
-
-
0036671332
-
Bispecific antibodies targeting cancer cells
-
PEIPP M, VALERIUS T: Bispecific antibodies targeting cancer cells. Biochem. Soc. Trans. (2002) 30(4):507-511.
-
(2002)
Biochem. Soc. Trans.
, vol.30
, Issue.4
, pp. 507-511
-
-
Peipp, M.1
Valerius, T.2
-
164
-
-
0033044588
-
Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity
-
UMAÑA P, JEAN-MAIRET J, MOUDRY R, AMSTUTZ H, BAILEY JE: Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat. Biotechnol. (1999) 17(2):176-180.
-
(1999)
Nat. Biotechnol.
, vol.17
, Issue.2
, pp. 176-180
-
-
Umaña, P.1
Jean-Mairet, J.2
Moudry, R.3
Amstutz, H.4
Bailey, J.E.5
-
165
-
-
0027368961
-
Recombinant soluble human Fcγ RII: Production, characterization, and inhibition of the Arthus reaction
-
IERINO FL, POWELL MS, MCKENIECK IF, HOGARTH PM: Recombinant soluble human Fcγ RII: production, characterization, and inhibition of the Arthus reaction. J. Exp. Med. (1993) 178(5):1617-1628.
-
(1993)
J. Exp. Med.
, vol.178
, Issue.5
, pp. 1617-1628
-
-
Ierino, F.L.1
Powell, M.S.2
McKenieck, I.F.3
Hogarth, P.M.4
-
166
-
-
0034972816
-
Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcγRIIB and is not associated with loci controlling diabetes
-
JOHANSSON AC, SUNDLER M, KJELLEN P et al.: Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcγRIIB and is not associated with loci controlling diabetes. Eur. J. Immunol. (2001) 31(6):1847-1856.
-
(2001)
Eur. J. Immunol.
, vol.31
, Issue.6
, pp. 1847-1856
-
-
Johansson, A.C.1
Sundler, M.2
Kjellen, P.3
-
167
-
-
1942499587
-
Fcγ receptors on mast cells: Activating and inhibitory regulation of mediator release
-
TRACZYK C, OKAYAMA Y, METCALFE DD, GLIFILLAN AM: Fcγ receptors on mast cells: activating and inhibitory regulation of mediator release. Int. Arch. Allergy Immunol. (2004) 133(3):305-315.
-
(2004)
Int. Arch. Allergy Immunol.
, vol.133
, Issue.3
, pp. 305-315
-
-
Traczyk, C.1
Okayama, Y.2
Metcalfe, D.D.3
Glifillan, A.M.4
-
168
-
-
0035983742
-
Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus
-
KYOGOKU C, DIJSTELBLOEM HM, TSUCHIYA N et al.: Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus. Arthritis Rheum. (2002) 46(5):1242-1254.
-
(2002)
Arthritis Rheum.
, vol.46
, Issue.5
, pp. 1242-1254
-
-
Kyogoku, C.1
Dijstelbloem, H.M.2
Tsuchiya, N.3
-
169
-
-
1842632236
-
Polymorphisms of the Fcγ receptor Type IIB gene are not associated with systemic lupus erythematosus in the Swedish population
-
MAGNUSSON V, ZUNEC R, ODEBERG J et al.: Polymorphisms of the Fcγ receptor Type IIB gene are not associated with systemic lupus erythematosus in the Swedish population. Arthritis. Rheum. (2004) 50(4):1348-1350.
-
(2004)
Arthritis Rheum.
, vol.50
, Issue.4
, pp. 1348-1350
-
-
Magnusson, V.1
Zunec, R.2
Odeberg, J.3
-
170
-
-
2442710233
-
A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIB alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus
-
SU K, WU J, EDBERG JC et al.: A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIB alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J. Immunol. (2004) 172(11):7186-7191.
-
(2004)
J. Immunol.
, vol.172
, Issue.11
, pp. 7186-7191
-
-
Su, K.1
Wu, J.2
Edberg, J.C.3
-
171
-
-
2442679050
-
A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIB alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function
-
SU K, LI X, EDBERG JC et al.: A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIB alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J. Immunol. (2004) 172(11):7192-7199.
-
(2004)
J. Immunol.
, vol.172
, Issue.11
, pp. 7192-7199
-
-
Su, K.1
Li, X.2
Edberg, J.C.3
-
172
-
-
0028256481
-
Functional analysis of human Fcγ RII (CD32) isoforms expressed in B lymphocytes
-
VAB DEN HERIK-OUDIJK IE, WESTERDAAL NA, HENRIQUEZ NV, CAPEL PJ, VAN DE WINKEL JG: Functional analysis of human Fcγ RII (CD32) isoforms expressed in B lymphocytes. J. Immunol. (1994) 152 2):574-585.
-
(1994)
J. Immunol.
, vol.152
, Issue.2
, pp. 574-585
-
-
Vab Den Herik-Oudijk, I.E.1
Westerdaal, N.A.2
Henriquez, N.V.3
Capel, P.J.4
Van De Winkel, J.G.5
-
173
-
-
0037187949
-
Immune thrombocytopenic purpura
-
CINES DB, BLANCHETTEI VS: Immune thrombocytopenic purpura. N. Engl. J. Med. (2002) 346(13):995-1008.
-
(2002)
N. Engl. J. Med.
, vol.346
, Issue.13
, pp. 995-1008
-
-
Cines, D.B.1
Blanchettei, V.S.2
-
174
-
-
0035436879
-
Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes
-
YUKI N: Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect. Dis. (2001) 1(1):29-37.
-
(2001)
Lancet Infect. Dis.
, vol.1
, Issue.1
, pp. 29-37
-
-
Yuki, N.1
-
175
-
-
0036259789
-
High-dose intravenous immunoglobulin treatment of multiple sclerosis
-
DURELLI L, ISOARDO G: High-dose intravenous immunoglobulin treatment of multiple sclerosis. Neurol. Sci. (2002) 23 Suppl, 1):S39-S48.
-
(2002)
Neurol. Sci.
, vol.23
, Issue.SUPPL. 1
-
-
Durelli, L.1
Isoardo, G.2
-
176
-
-
0034774825
-
Use of intravenous gamma globulins in neuroimmunologic diseases
-
LATOV N, CHAUDHRY V, KOSKI CL et al.: Use of intravenous gamma globulins in neuroimmunologic diseases. J. Allergy. Clin. Immunol. (2001) 108(4 Suppl.):S126-S132.
-
(2001)
J. Allergy Clin. Immunol.
, vol.108
, Issue.4 SUPPL.
-
-
Latov, N.1
Chaudhry, V.2
Koski, C.L.3
-
177
-
-
0036221826
-
Intravenous immunoglobulin in neurological disease: A specialist review
-
WILES CM, BROWN P, CHAPEL H et al.: Intravenous immunoglobulin in neurological disease: a specialist review. J. Neurol. Neurosurg. Psychiatry (2002) 72(4):440-448.
-
(2002)
J. Neurol. Neurosurg. Psychiatry
, vol.72
, Issue.4
, pp. 440-448
-
-
Wiles, C.M.1
Brown, P.2
Chapel, H.3
-
178
-
-
0035230888
-
Kawasaki disease
-
BURNS JC: Kawasaki disease. Adv. Pediatr. (2001) 48 157-177.
-
(2001)
Adv. Pediatr.
, vol.48
, pp. 157-177
-
-
Burns, J.C.1
-
179
-
-
0036884344
-
Immunomodulatory action of intravenous immunoglobulin
-
SEWELL WA, JOLLES S: Immunomodulatory action of intravenous immunoglobulin. Immunology (2002) 107(4):387-393.
-
(2002)
Immunology
, vol.107
, Issue.4
, pp. 387-393
-
-
Sewell, W.A.1
Jolles, S.2
-
180
-
-
0038300763
-
IVIg - Mechanisms of action
-
SIMON HU, SPATH PJ: IVIg - mechanisms of action. Allergy (2003) 58(7):543-552.
-
(2003)
Allergy
, vol.58
, Issue.7
, pp. 543-552
-
-
Simon, H.U.1
Spath, P.J.2
-
181
-
-
0038377261
-
Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
-
BAYRY J, MISRA N, LATRY V et al.: Mechanisms of action
-
(2003)
Tansfus. Clin. Biol.
, vol.10
, Issue.3
, pp. 165-169
-
-
Bayry, J.1
Misra, N.2
Latry, V.3
-
182
-
-
0035910392
-
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
-
SAMUELSSON A, TOWERS TL, RAVETCH JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science (2001) 291(5503):484-486.
-
(2001)
Science
, vol.291
, Issue.5503
, pp. 484-486
-
-
Samuelsson, A.1
Towers, T.L.2
Ravetch, J.V.3
-
183
-
-
0037399064
-
Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease
-
BRUHNS P, SAMUELSSON A, POLLARD JW, RAVETCH JV: Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity (2003) 18(4):573-581.
-
(2003)
Immunity
, vol.18
, Issue.4
, pp. 573-581
-
-
Bruhns, P.1
Samuelsson, A.2
Pollard, J.W.3
Ravetch, J.V.4
-
184
-
-
0038494827
-
IVIg-mediated amelioration of murine ITP via FcγRIIB is independent of SHIP1, SHP-1, and Btk activity
-
CROW AR, SONG S, FREEDMAN J et al.: IVIg-mediated amelioration of murine ITP via FcγRIIB is independent of SHIP1, SHP-1, and Btk activity. Blood (2003) 102(2):558-560.
-
(2003)
Blood
, vol.102
, Issue.2
, pp. 558-560
-
-
Crow, A.R.1
Song, S.2
Freedman, J.3
-
185
-
-
2342524131
-
The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease
-
AKILESH S, PETKOVA S, SPROULE TJ, SHAFFER DJ, CHRISTIANSON GJ, ROOPENIAN D: The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J. Clin. Invest. (2004) 113 9):1328-1333.
-
(2004)
J. Clin. Invest.
, vol.113
, Issue.9
, pp. 1328-1333
-
-
Akilesh, S.1
Petkova, S.2
Sproule, T.J.3
Shaffer, D.J.4
Christianson, G.J.5
Roopenian, D.6
-
186
-
-
0029875055
-
Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor
-
MCDONNEL JM, BEAVIL AJ, MACKAY GA et al.: Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nat. Struct. Biol. (1996) 5 3):419-426.
-
(1996)
Nat. Struct. Biol.
, vol.5
, Issue.3
, pp. 419-426
-
-
Mcdonnel, J.M.1
Beavil, A.J.2
Mackay, G.A.3
-
187
-
-
0033911048
-
Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide
-
MARINO M, RUVO M, DE FALCO S, FASSINA G: Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide. Nat. Biotechnol. (2000) 18 7):735-739.
-
(2000)
Nat. Biotechnol.
, vol.18
, Issue.7
, pp. 735-739
-
-
Marino, M.1
Ruvo, M.2
De Falco, S.3
Fassina, G.4
-
188
-
-
1642362513
-
Synthesis and receptor binding of IgG1 peptides derived from the IgG Fc region
-
URAY K, MEDGYESI D, HILBERT A, SARMAY G, GERGELY J, HUDECZ F: Synthesis and receptor binding of IgG1 peptides derived from the IgG Fc region. J. Mol. Recognit. (2004) 17(2):95-105.
-
(2004)
J. Mol. Recognit.
, vol.17
, Issue.2
, pp. 95-105
-
-
Uray, K.1
Medgyesi, D.2
Hilbert, A.3
Sarmay, G.4
Gergely, J.5
Hudecz, F.6
-
189
-
-
3843123356
-
Functional mapping of the FcγRII binding site on human IgG1 by synthetic peptides
-
MEDGYSEI D, URAY K, SALLAI K et al.: Functional mapping of the FcγRII binding site on human IgG1 by synthetic peptides. Eur. J. Immunol. (2004) 34(4):1127-1135.
-
(2004)
Eur. J. Immunol.
, vol.34
, Issue.4
, pp. 1127-1135
-
-
Medgysei, D.1
Uray, K.2
Sallai, K.3
|